Tanvex BioPharma Tanvex BioPharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs. | Bellicum Pharmaceuticals Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing cellular immunotherapies. | ||||
Founding Date | Founding Date 1992 | Founding Date 2013 | Founding Date 2011 | Founding Date 2009 | Founding Date 2004 |
Type | Type Public | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Somerville, US HQ | Locations Taipei, TW HQ New Taipei, TW Irvine, US San Diego, US San Diego, US | Locations Cambridge, US HQ | Locations West Lake Hills, US HQ Austin, US | Locations Houston, US HQ Houston, US Houston, US South San Francisco, US |
Employees | Employees 32338% decrease | Employees 13628% decrease | Employees 378% decrease | Employees 2865% increase | Employees 1386% increase |
Valuation ($) | Valuation ($) 95.4 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 6.3 m | Valuation ($) 778.3 k |
Financial | |||||
Revenue (est.) | Revenue (est.) $3.6m (FY, 2022) | Revenue (est.) NT$61.4m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $1.5m (FY, 2022) |
Net income | Net income ($266.6m) (FY, 2022) | Net income (NT$2.1b) (FY, 2023) | Net income N/A | Net income ($30.9m) (FY, 2023) | Net income ($25m) (FY, 2022) |
Funding | |||||
Total funding raised | Total funding raised $ 409m | Total funding raised $ 346.9m | Total funding raised $ 200m | Total funding raised N/A | Total funding raised N/A |